C

Clariant AG
SIX:CLN

Watchlist Manager
Clariant AG
SIX:CLN
Watchlist
Price: 7.16 CHF -0.35%
Market Cap: CHf2.4B

Clariant AG
Investor Relations

In the shadow of the Swiss Alps, Clariant AG has carved out its niche as a formidable player in the specialty chemicals landscape. Emerging from the restructuring endeavors of Sandoz in the mid-1990s, Clariant embarked on a journey of metamorphosis, morphing from a collection of diverse chemical assets into a global leader in specialty chemicals. Known for its strategic focus on innovation and sustainability, Clariant divides its operations into critical business areas: Care Chemicals, Catalysis, and Natural Resources. Whether creating advanced emulsifiers for personal care products, catalysts that drive higher yields for petrochemicals, or additives that enhance oil recovery, Clariant continuously adapts to market demands through a commitment to research and development, placing a premium on delivering high-performance and sustainable solutions across industries.

Clariant’s business model is deeply tied to innovation-driven solutions that cater to the evolving needs of its clients. The company invests significantly in R&D, with laboratories and research centers spread across strategic global locations, fostering a culture of innovation that synergizes with local markets. Through its intelligent use of its portfolio, Clariant generates revenue by not only meeting the basic needs of its customers but by shaping their expectations toward value-added, environmentally friendly products. This has garnered them a reputation for leadership in sustainability, evidenced by their initiatives aimed at reducing their environmental footprint and facilitating the transition to a low-carbon economy. By focusing on these strategic pillars, Clariant continues to secure its financial position, creating shareholder value while contributing positively to society at large.

Show more
Loading
CLN
Swiss Market Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Oct 30, 2025
AI Summary
Q3 2025

Revenue: Clariant reported Q3 sales of CHF 906 million, down 3% in local currency and 9% in Swiss francs, reflecting ongoing market headwinds.

Profitability: EBITDA before exceptional items rose 5% to CHF 162 million, with a 230 basis point margin improvement to 17.9%, highlighting successful cost and price management.

Savings Program: CHF 19 million in savings were achieved in Q3, bringing year-to-date savings to CHF 31 million towards the CHF 80 million target by 2027.

Guidance: 2025 EBITDA margin guidance of 17–18% was reiterated, but full-year local currency sales growth is expected at the low end (1%) of the previously guided 1–3% range.

CapEx: 2025 CapEx guidance was lowered to CHF 180 million, reflecting a shift to maintenance spending after major projects in China were completed.

Board Changes: The Board will shrink from 11 to 8 members by April 2026, improving independence, tenure, and gender diversity.

Market Conditions: Management cited continued weak industrial production, soft consumer sentiment, and trade/tariff uncertainties as ongoing headwinds.

Key Financials
Sales
CHF 906 million
EBITDA before exceptional items
CHF 162 million
EBITDA margin before exceptional items
17.9%
Reported EBITDA
CHF 159 million
Restructuring charges (Q3 2025)
CHF 3 million
Total savings (first 9 months 2025)
CHF 31 million
CapEx (2025 guidance)
CHF 180 million
Headcount reduction (by September 30, 2025)
approximately 340 full-time equivalents
Care Chemicals EBITDA before exceptional items (Q3 2025)
CHF 92 million
Care Chemicals EBITDA margin before exceptional items
18.9%
Catalysts EBITDA before exceptional items
CHF 33 million
Catalysts EBITDA margin before exceptional items
19.3%
Adsorbents and Additives EBITDA before exceptional items
CHF 42 million
Adsorbents and Additives EBITDA margin before exceptional items
17.2%
Earnings Call Recording
Other Earnings Calls

Management

Mr. Richard Haldimann Ph.D.
Chief Technology & Sustainability Officer and Head of New Business Development
No Bio Available
Mr. Andreas Schwarzwaelder
Head of Investor Relations
No Bio Available
Dr. Judith Bischoff
General Counsel & Head of Group Legal Services
No Bio Available
Kai Rolker
Head of Group Communications
No Bio Available
Mr. Chris Hansen
Chief Corporate Development Officer
No Bio Available
Ms. Tatiana Berardinelli
Chief Human Resources Officer
No Bio Available
Mr. Joachim Krüger
Head of Corporate Sustainability & Regulatory Affairs
No Bio Available
Monica Ferreira
Region Head of Latin America
No Bio Available
Mr. Christian Vang
President of BU Care Chemicals & Americas Region
No Bio Available
Dr. Stefan Ohren
Head of Product Management High Performance Polycyclic Pigments
No Bio Available

Contacts

Address
BASEL-LANDSCHAFT
Muttenz
Rothausstrasse 61
Contacts